Women in England with breast cancer may qualify for drug that buys ‘precious’ time

The National Institute for Health and Care Excellence (Nice) has overturned its draft rejection of Keytruda (pembrolizumab) and said women in England can take the drug in combination with chemotherapy.

Read more at www.theguardian.com